Dave Kaysen

Mr. Kaysen has 35+ years of executive level experience leading and managing both domestic and international emerging growth companies. Mr. Kaysen has achieved consistent and solid results with technology, bio-pharmaceutical, medical device, diagnostic and clinical software/IT companies. He is experienced in the FDA approval process, leading products from development stage through commercialization and revenue growth. Prior to joining Atrility Medical LLC as President and CEO, Mr. Kaysen served as Chairman, President, CEO and Board member of Medibio Limited, an Australian listed medtech software/IT company focused on mental health. He was President, CEO and Board member of Sun BioPharma, Inc., a publicly traded biopharmaceutical company developing a drug for pancreatic cancer. He was also President, CEO and Board member of Uroplasty, Inc. a publicly traded global medical device company focused on female urinary disorders. Prior to that he served as President, CEO and Board member of Diametrics Medcial, Inc. a global diagnostics company and Rehablicare, Inc. a publicly traded global orthopedic and rehabilitation neuromodulation company. Mr. Kaysen currently serves as the Chairman of the Board of privately held Interrad Medical and as an Advisory Board member of EXB Solutions and Atlantic Therapeutics.